SCHEMBL29593245

SCHEMBL29593245

Cn1c(=O)c(Cc2ccc(F)cc2)cc2cnc(Nc3ccc(F)cc3)nc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 5/20 0.60
FGFR1 P11362 5/20 0.60
MAPK14 Q16539 4/20 0.60
ABL1 P00519 3/20 0.60
PDGFRB P09619 3/20 0.60
PDGFRA P16234 3/20 0.60
EGFR P00533 3/20 0.60
KIT P10721 2/20 0.60
WEE1 P30291 5/20 0.53
PLK2 Q9NYY3 3/20 0.52
CDK4 P11802 1/20 0.52
CCND1 P24385 1/20 0.52
CCND2 P30279 1/20 0.52
CCND3 P30281 1/20 0.52
USP2 O75604 1/20 0.51
CYP1A2 P05177 1/20 0.51
FGFR3 P22607 2/20 0.51
LCK P06239 1/20 0.51
FLT3 P36888 1/20 0.51
PLK1 P53350 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5116444 1.00 SRC (0.60) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL5114082 0.95 WEE1 (0.60) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL14014933 0.93 SRC (0.61) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL13553949 0.89 FGFR1 (0.62) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL13553963 0.88 PLK2 (0.56) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL13553977 0.88 PLK2 (0.61) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL13553960 0.88 PLK2 (0.71) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL13553962 0.87 PLK2 (0.56) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL14014925 0.87 WEE1 (0.66) SRCFGFR1MAPK14ABL1PDGFRB
SCHEMBL5109835 0.84 FGFR1 (0.58) SRCFGFR1MAPK14ABL1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-09-24 CN disclosed
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed